News

Eli Lilly (NYSE:LLY ... The latest executive order on drug prices by President Donald Trump has only added to its woes, or has it? The order signed on May 12 aims to align U.S. drug prices ...
The global weight-loss drug market is experiencing exceptional growth, projected to expand from around $144.6 billion in 2023 ...
Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...
Pharmaceutical stocks, including Merck (MRK), Pfizer (PFE), and Eli Lilly (LLY ... a new executive order that will push drugmakers to sell prescription drugs at a lower price and directly to ...
The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...
Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...
US President Donald Trump has signed an executive order that aims to reduce high prescription drug prices – but its details ...
The U.S. imports more pharmaceutical products from Ireland than from any other country -- nearly $50 billion last year. It won't be surprising if the Trump administration especially targets those ...
Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...
Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...
Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, ...